Orient Europharma to start neck cancer drug Phase III trial in Taiwan
Orient Europharma intends to team up with 6 other Taiwanese clinical centers for conducting the study, named as immunotherapy Multikine anti tumor treatments (IT-MATTERS), which is already ongoing
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.